MeSH D001859 - bone neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Zoledronic acid | Zoledronic acid Teva | 2012-08-16 | |||
| Zoledronic acid | Zoledronic acid Teva Generics | 2014-03-27 | ||||
| Zoledronic acid | Zoledronic acid Teva Pharma | 2012-08-15 | ||||
| Mylan | Zoledronic acid | Zoledronic Acid | 2013-03-04 | |||
| Zoledronic acid | Zoledronic acid Mylan | 2012-08-23 | ||||
| Sandoz | Zoledronic acid | Aclasta | 2005-04-15 | |||
| Zoledronic acid | Reclast | 2023-10-27 | 2007-04-16 | |||
| Novartis | Zoledronic acid | Zometa | 2025-05-29 | 2001-08-20 | ||
| Pfizer | Zoledronic acid | Zoledronic Acid Hospira | 2012-11-19 | |||
| Dr Reddys Laboratories | Zoledronic acid | Zoledronic Acid | 2013-03-04 | |||
| Sun Pharmaceutical Industries | Zoledronic acid | Zoledronic Acid | 2013-03-04 | |||
| Apotex | Zoledronic acid | Zoledronic Acid | 2015-12-24 | |||
| Breckenridge Pharmaceutical | Zoledronic acid | Zoledronic Acid | 2013-03-04 | |||
| Hospira | Zoledronic acid | Zoledronic Acid | 2015-03-19 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
80%24/30
Phase 2
23%10/44
Phase 3
9%3/32
Approved: 1Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use